Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab

Abu Shtaya, Aasem and Cohen, Shai and Kogan, Yana and Shteinberg, Michal and Sagool, Ori (2021) Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab. European Journal of Case Reports in Internal Medicine, 8 (2). pp. 1-4. ISSN ISSN: 2284-2594

[img]
Preview
Text
2265-Article Text-20746-1-10-20210217.pdf - Published Version

Download (664kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/issue/view...

Abstract

Crohn’s disease is a chronic inflammatory bowel disease that can affect any part of the GI tract, which is frequently associated with extra-intestinal manifestations. Pulmonary parenchymal disease is very uncommon and usually considered to be debilitating and harder to diagnose. Pulmonary granulomas are rarely described in the literature as a complication of Crohn’s disease. Here, we present a patient with Crohn’s disease exacerbation who developed granulomatous lung disease under treatment with vedolizumab. Our case may add evidence to the emerging theory that gut-selective biologic agents could lead to upregulation of some pro-inflammatory factors leading to the evolution of pulmonary disease.

Item Type: Article
Uncontrolled Keywords: Crohn’s disease, granuloma, vedolizumab, infliximab
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 20 Dec 2021 15:13
Last Modified: 20 Dec 2021 15:13
URI: http://eprints.bice.rm.cnr.it/id/eprint/21177

Actions (login required)

View Item View Item